Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy
Table 1
Association between NLR and clinicopathologic characteristics of LACSCC patients.
Clinicopathologic characteristics
NLR, (%)
value
≥2.0
<2.0
Age
≤50 years
21 (77.7)
6 (22.3)
0.017
>50 years
15 (45.4)
18 (54.6)
Histologic grade
Well and moderately differentiated
18 (58.0)
13 (42.0)
0.797
Poorly differentiated
18 (62.0)
11 (38.0)
Tumor size
≤4 cm
9 (45.0)
11 (55.0)
0.105
>4 cm
27 (67.5)
13 (32.5)
Parametrial invasion
No
16 (55.1)
13 (44.9)
0.595
Unilateral
14 (60.8)
9 (39.2)
Bilateral
6 (75.0)
2 (25.0)
Clinical lymph node involvement
cN0
24 (54.5)
20 (45.5)
0.234
cN1
12 (75.0)
4 (25.0)
FIGO stage
II
20 (55.5)
16 (44.5)
0.432
III
16 (66.6)
8 (33.4)
Hemoglobin levels at diagnosis (g/dL)
≤113
7 (53.8)
6 (46.2)
0.751
>113
29 (61.7)
18 (38.3)
Platelets at diagnosis (g/dL)
≤320
9 (90.0)
1 (10.0)
0.040
>320
27 (54.0)
23 (46.0)
Response
CR
20 (58.8)
14 (41.2)
1.000
Non-CR
16 (61.5)
10 (38.5)
NLR, neutrophil-lymphocyte ratio; LACSCC, locally advanced cervical squamous cell carcinomas; FIGO, International Federation of Gynecology and Obstetrics; CR, complete response.
